Related references
Note: Only part of the references are listed.A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Nicholas J. Boddicker et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes
Allison W. Kurian et al.
JCO PRECISION ONCOLOGY (2021)
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
Irene Rainville et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)
Tuya Pal et al.
GENETICS IN MEDICINE (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
Siddhartha Yadav et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer
Allison W. Kurian et al.
JAMA ONCOLOGY (2020)
Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer
Allison W. Kurian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Racial disparities in breast cancer hereditary risk assessment referrals
Jennifer M. Peterson et al.
JOURNAL OF GENETIC COUNSELING (2020)
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period
Lisa Esterling et al.
JCO PRECISION ONCOLOGY (2020)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients
Yanin Chavarri-Guerra et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons
Eric R. Manahan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Allison W. Kurian et al.
JAMA ONCOLOGY (2018)
Outcomes of retesting BRCA negative patients using multigene panels
Siddhartha Yadav et al.
FAMILIAL CANCER (2017)
Complexities of Variant Classification in Clinical Hereditary Cancer Genetic Testing
Erin Mundt et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories
Eric T. Rosenthal et al.
CANCER GENETICS (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients
Beth Crawford et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes
Saundra S. Buys et al.
CANCER (2017)
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women
Allison W. Kurian et al.
JCO PRECISION ONCOLOGY (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Ella R. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer
Nimmi S. Kapoor et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond et al.
JAMA ONCOLOGY (2015)
Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel
Nadine Tung et al.
CANCER (2015)
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer
Kara N. Maxwell et al.
GENETICS IN MEDICINE (2015)
A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes
J. M. Eggington et al.
CLINICAL GENETICS (2014)
Gene Panel Testing for Inherited Cancer Risk
Michael J. Hall et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Share Paper
